Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Dong Xiao

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Authors' replyDe-Hua Chang, Yu-Dong Xiao, Tong Yao
Alimentary Pharmacology & Therapeutics|March 13, 2023
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates - authors' replyYao Tong, De-Hua Chang, Yu-Dong Xiao
Hepatology (Baltimore, Md.)|December 26, 2023
Letter to the Editor: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?Tian-Cheng Wang, Yu-Dong Xiao, Peng Zhou
Annals of Surgical Oncology|December 24, 2022
ASO Author Reflections: The FIBA Score-A Novel Scoring System to Predict Outcomes in Hepatocellular Carcinoma After Surgical Resection or Transarterial ChemoembolizationDe-Hua Chang, Yu-Dong Xiao, Yao Tong
European Radiology|November 11, 2018
Cavographic vs. cross-sectional measurement of the inferior vena cava diameter before filter placement: are we routinely oversizing?Yu-Dong Xiao, Zi-Shu Zhang, Cong Ma
Journal of Pain Research|April 11, 2020
Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular CarcinomaTian-Cheng Wang, Zi-Shu Zhang, Yu-Dong Xiao
Cancer Management and Research|March 14, 2019
Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experienceYu-Dong Xiao, Cong Ma, Zi-Shu Zhang, et al.
BMC Cancer|December 1, 2019
Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safetyZi-Shu Zhang, Hui-Zhou Li, Cong Ma, et al.
Insights Into Imaging|March 6, 2021
Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?Zhi-Min Zou, De-Hua Chang, Hui Liu, et al.
Frontiers in Oncology|November 4, 2021
Initial Incomplete Thermal Ablation Is Associated With a High Risk of Tumor Progression in Patients With Hepatocellular CarcinomaJie Tan, Tian Tang, Wei Zhao, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Authors' replyDe-Hua Chang, Yu-Dong Xiao, Tong Yao
Alimentary Pharmacology & Therapeutics|March 13, 2023
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates - authors' replyYao Tong, De-Hua Chang, Yu-Dong Xiao
Hepatology (Baltimore, Md.)|December 26, 2023
Letter to the Editor: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?Tian-Cheng Wang, Yu-Dong Xiao, Peng Zhou
Annals of Surgical Oncology|December 24, 2022
ASO Author Reflections: The FIBA Score-A Novel Scoring System to Predict Outcomes in Hepatocellular Carcinoma After Surgical Resection or Transarterial ChemoembolizationDe-Hua Chang, Yu-Dong Xiao, Yao Tong
European Radiology|November 11, 2018
Cavographic vs. cross-sectional measurement of the inferior vena cava diameter before filter placement: are we routinely oversizing?Yu-Dong Xiao, Zi-Shu Zhang, Cong Ma
Journal of Pain Research|April 11, 2020
Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular CarcinomaTian-Cheng Wang, Zi-Shu Zhang, Yu-Dong Xiao
Cancer Management and Research|March 14, 2019
Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experienceYu-Dong Xiao, Cong Ma, Zi-Shu Zhang, et al.
BMC Cancer|December 1, 2019
Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safetyZi-Shu Zhang, Hui-Zhou Li, Cong Ma, et al.
Insights Into Imaging|March 6, 2021
Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?Zhi-Min Zou, De-Hua Chang, Hui Liu, et al.
Frontiers in Oncology|November 4, 2021
Initial Incomplete Thermal Ablation Is Associated With a High Risk of Tumor Progression in Patients With Hepatocellular CarcinomaJie Tan, Tian Tang, Wei Zhao, et al.
Pageof 5